Orthopaedic device company Additive Orthopaedics LLC revealed on Wednesday that it has passed the US FDA's 510(k) clearance for its Patient Specific 3D Printed Bone Segments to address internal bone fixation in the ankle and foot global extremities market.
This is a tremendous milestone for orthopaedics and the obvious trend towards patient specific 3D printed implants. In cases of implant revision, limb salvage, and trauma, often there are no clinically available devices to address the patient's condition. This is where 3D printed patient specific implants are making significant clinical impacts, according to Greg Kowalczyk, president of Additive Orthopaedics.
In several patients, its lattice structures have shown close to 90% boney in-growth after six months using no biologics. It is excited to now offer these as patient specific solutions, added Brian McLaughlin, VP of Engineering and Operations,
According to the company, it has seen over 1000 devices implanted since their commercial launch in early 2017 as well as closed a Series B Round of USD1m.
Halma acquires Rovers Medical Devices
boston Scientific granted FDA approval for AGENT Drug-Coated Balloon
Enable Injections names new chief operating officer
BridgeBio Pharma and Kyowa Kirin partner on infigratinib for skeletal dysplasias in Japan
Redwood Scientific signs agreement with Jeeva Clinical Trials
Tissue Regenix ships first allograft products in the EU post-HPRA approval
Kromek secures GBP1.3m grant for AI-powered radiation sensor project